With increasing reports of KPNA2 involvement in several cancer types [6, 7, 9, 15] and significant advancements in precision medicine technologies, coupled to extensive biobanking and electronic curation of patient metadata, the scope exists to interrogate the correlation between KPNA2 expression, breast cancer phenotype and patient prognosis. The gene discussed is KPNA2; the disease is breast carcinoma.